NEO-LARYNGOBIS
NEO-LARYNGOBIS
Approved
DIN Number
00065927
Drug Class
Human
Market Date
Dec 31, 1950
Company
HC
teva canada limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number00065927
AIG Number0108681002
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
R02AA20 VARIOUS
Product Specifications
Dosage FormSuppository
Route of AdministrationRectal
AHFS Classification52:92.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
BISMUTH DIPROPYLACETATEActive
Strength: 135 MG
Monograph: BISMUTH DIPROPYLACETATE